Junpeng Huang

717 total citations
31 papers, 539 citations indexed

About

Junpeng Huang is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Junpeng Huang has authored 31 papers receiving a total of 539 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 8 papers in Cancer Research and 6 papers in Immunology. Recurrent topics in Junpeng Huang's work include Cancer-related gene regulation (7 papers), RNA modifications and cancer (7 papers) and Epigenetics and DNA Methylation (5 papers). Junpeng Huang is often cited by papers focused on Cancer-related gene regulation (7 papers), RNA modifications and cancer (7 papers) and Epigenetics and DNA Methylation (5 papers). Junpeng Huang collaborates with scholars based in China, United States and Hong Kong. Junpeng Huang's co-authors include Yanfang Zheng, Jiren Zhang, Rong Zeng, Xufeng Li, Jcm Ho, Jun Ren, Yipei Jing, Zailin Yang, Meixi Peng and Changchao Huan and has published in prestigious journals such as Free Radical Biology and Medicine, International Journal of Molecular Sciences and Nutrients.

In The Last Decade

Junpeng Huang

29 papers receiving 536 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junpeng Huang China 15 279 158 74 60 53 31 539
Linping Hu China 14 303 1.1× 71 0.4× 34 0.5× 61 1.0× 61 1.2× 29 589
Tengteng Xu China 13 259 0.9× 97 0.6× 68 0.9× 32 0.5× 33 0.6× 29 422
Hongbo Zhao China 17 319 1.1× 127 0.8× 22 0.3× 80 1.3× 84 1.6× 66 693
Lihong Shi China 14 289 1.0× 92 0.6× 22 0.3× 68 1.1× 87 1.6× 50 659
Mingjuan Liao China 14 230 0.8× 104 0.7× 30 0.4× 68 1.1× 29 0.5× 28 474
Songbai Liu China 16 471 1.7× 121 0.8× 26 0.4× 121 2.0× 44 0.8× 74 755
Zhongbin Zhang China 12 180 0.6× 111 0.7× 32 0.4× 45 0.8× 33 0.6× 32 387
Jaya Prakash Golla United States 13 231 0.8× 57 0.4× 41 0.6× 59 1.0× 64 1.2× 22 434
Guomin Zhang China 12 287 1.0× 144 0.9× 54 0.7× 29 0.5× 44 0.8× 38 513
Feifei Yuan China 14 260 0.9× 85 0.5× 99 1.3× 94 1.6× 119 2.2× 29 661

Countries citing papers authored by Junpeng Huang

Since Specialization
Citations

This map shows the geographic impact of Junpeng Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junpeng Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junpeng Huang more than expected).

Fields of papers citing papers by Junpeng Huang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junpeng Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junpeng Huang. The network helps show where Junpeng Huang may publish in the future.

Co-authorship network of co-authors of Junpeng Huang

This figure shows the co-authorship network connecting the top 25 collaborators of Junpeng Huang. A scholar is included among the top collaborators of Junpeng Huang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junpeng Huang. Junpeng Huang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Haocheng, Junpeng Huang, Ziying Wu, et al.. (2025). PPIF+ neutrophils promote mtROS driven NETosis mediated progression of colorectal cancer. Journal of Translational Medicine. 23(1). 1259–1259.
3.
Pfob, André, Jia Liu, Christopher J. Sidey-Gibbons, et al.. (2024). 147P Racial bias in pretreatment MRI radiomics features to predict response to neoadjuvant systemic treatment in breast cancer: A multicenter study in China, Germany, and the US. ESMO Open. 9. 103134–103134. 2 indexed citations
4.
Ren, Jun, Junpeng Huang, Zailin Yang, et al.. (2024). Cytoplasmic TP53INP2 acts as an apoptosis partner in TRAIL treatment: the synergistic effect of TRAIL with venetoclax in TP53INP2-positive acute myeloid leukemia. Journal of Experimental & Clinical Cancer Research. 43(1). 176–176. 4 indexed citations
5.
Huang, Junpeng, et al.. (2023). Assessment of Biological Activity of 28-Homobrassinolide via a Multi-Level Comparative Analysis. International Journal of Molecular Sciences. 24(11). 9377–9377. 2 indexed citations
6.
Wang, Qian, Jun Ren, Yipei Jing, et al.. (2023). Glucose induced-AKT/mTOR activation accelerates glycolysis and promotes cell survival in acute myeloid leukemia. Leukemia Research. 128. 107059–107059. 13 indexed citations
7.
Huang, Junpeng, Ming‐Hui Sun, Jun Ren, et al.. (2023). Cytoplasmic Expression of TP53INP2 Modulated by Demethylase FTO and Mutant NPM1 Promotes Autophagy in Leukemia Cells. International Journal of Molecular Sciences. 24(2). 1624–1624. 18 indexed citations
9.
Huang, Junpeng, et al.. (2022). Non-Esterified Fatty Acid Induces ER Stress-Mediated Apoptosis via ROS/MAPK Signaling Pathway in Bovine Mammary Epithelial Cells. Metabolites. 12(9). 803–803. 14 indexed citations
10.
Dai, Yongmei, et al.. (2022). Multiomics Integrative Analysis Identifying EPC1 as a Prognostic Biomarker in Head and Neck Squamous Cell Carcinoma. BioMed Research International. 2022(1). 1074412–1074412. 2 indexed citations
11.
Dai, Yongmei, et al.. (2022). Identification of key pathways and genes in nasopharyngeal carcinoma based on WGCNA. Auris Nasus Larynx. 50(1). 126–133. 2 indexed citations
12.
Ren, Jun, Meixi Peng, Yipei Jing, et al.. (2022). Targeted activation of GPER enhances the efficacy of venetoclax by boosting leukemic pyroptosis and CD8+ T cell immune function in acute myeloid leukemia. Cell Death and Disease. 13(10). 915–915. 18 indexed citations
13.
Li, Lei, Jun Ren, Meixi Peng, et al.. (2022). Mutant NPM1-Regulated FTO-Mediated m6A Demethylation Promotes Leukemic Cell Survival via PDGFRB/ERK Signaling Axis. Frontiers in Oncology. 12. 817584–817584. 20 indexed citations
14.
Huang, Junpeng, et al.. (2022). H2O2-induced oxidative stress impairs meat quality by inducing apoptosis and autophagy via ROS/NF-κB signaling pathway in broiler thigh muscle. Poultry Science. 101(4). 101759–101759. 34 indexed citations
15.
Peng, Meixi, Jun Ren, Yipei Jing, et al.. (2022). Circulating plasma exosomal long non-coding RNAs LINC00265, LINC00467, UCA1, and SNHG1 as biomarkers for diagnosis and treatment monitoring of acute myeloid leukemia. Frontiers in Oncology. 12. 1033143–1033143. 27 indexed citations
16.
Dai, Yongmei, et al.. (2021). FCGR2A Could Function as a Prognostic Marker and Correlate with Immune Infiltration in Head and Neck Squamous Cell Carcinoma. BioMed Research International. 2021(1). 8874578–8874578. 9 indexed citations
17.
Jing, Yipei, Meixi Peng, Jun Ren, et al.. (2021). Mutant NPM1-regulated lncRNA HOTAIRM1 promotes leukemia cell autophagy and proliferation by targeting EGR1 and ULK3. Journal of Experimental & Clinical Cancer Research. 40(1). 312–312. 36 indexed citations
18.
Dai, Yongmei, Chen Huang, Junpeng Huang, et al.. (2021). Expression and Biological Functions of EPC1 in Nasopharyngeal Carcinoma. Archives of Iranian Medicine. 24(11). 845–851. 2 indexed citations
19.
Zeng, Rong, Yi Liu, Junpeng Huang, et al.. (2018). EPB41L3 is a potential tumor suppressor gene and prognostic indicator in esophageal squamous cell carcinoma. International Journal of Oncology. 52(5). 1443–1454. 35 indexed citations
20.
Huang, Junpeng, Gang Wu, Rong Zeng, et al.. (2017). Chromium contributes to human bronchial epithelial cell carcinogenesis by activating Gli2 and inhibiting autophagy. Toxicology Research. 6(3). 324–332. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026